
Coalition's Conversation: The Employer Perspective
Key Takeaways
- The series empowers employers with strategies to incorporate GLP-1 therapies for obesity management in the workforce.
- Aon's analysis and PHTI's white paper highlight trends in employer adoption and digital solution integration.
Obesity market overview for employers: data on GLP-1s for obesity, digital solutions, and benefit strategies to control costs and outcomes.
The Coalition’s Conversation podcast series is a 3-part discussion on how employers can incorporate glucagon-like peptide-1 (GLP-1) therapies into a sustainable strategy to address obesity and weight loss in the workforce. This particular series, created in partnership between The American Journal of Managed Care® and the
In the second part of the series, we will explore findings from Aon’s extensive analysis of 50 million commercially insured lives and Peterson Health Technology Institute’s (PHTI) white paper on employer strategies and the integration of Digital Solutions. This session will illuminate key trends in employer adoption and showcase how data-driven decision-making can address one of today’s most pressing health care challenges.
Speakers:
- Tom Belmont, AP, CLU, ChFC, RHU, REBC, president and CEO of the Greater Philadelphia Business Coalition on Health (Series host and moderator)
- Alexander Pfau, vice president of Aon
- Lindsey Schapiro, associate director of Peterson Health Technology Institute (PHTI)




